<DOC>
	<DOCNO>NCT02232425</DOCNO>
	<brief_summary>The purpose study determine effectiveness IX-01 men lifelong premature ejaculation .</brief_summary>
	<brief_title>IX-01 Effect Intravaginal Ejaculatory Latency Time ( IELT ) Patient Reported Outcomes Men With Premature Ejaculation ( PE )</brief_title>
	<detailed_description />
	<mesh_term>Premature Birth</mesh_term>
	<mesh_term>Premature Ejaculation</mesh_term>
	<criteria>In stable ( ≥ 6 month ) heterosexual relationship Have lifelong ( primary ) premature ejaculation Have premature ejaculation confirm IELT less equal ( ≤ ) 1 minute ≥ 75 % attempt sexual intercourse Meet aspect International Society Sexual Medicine ( ISSM ) definition lifelong PE , include inability delay ejaculation nearly vaginal penetration negative personal consequence distress , bother frustration Willing attempt intercourse least 4 time runin period least 8 time doubleblind part study Not plan pregnancy partner willing use contraception ( unless childbearing potential , e.g. , surgically sterilise ) Willing limit use alcohol day take study drug ( three drink , one drink define 12 ounce ( oz ) , 360 milliliter ( mL ) bottle beer , 5 oz ( 150 mL ) glass wine , 1½ oz ( 45 mL distil spirit ) Capable give write informed consent An IELT value ≥ 2 minute runin period Less ( &lt; ) 4 attempt sexual intercourse runin ( screen may extend patient may rescreened extenuate circumstance ) A rating control ejaculation fair , good , good PEP questionnaire prior study Coexisting Erectile Dysfunction International Index Erectile Dysfunction ( IIEF ) erectile function domain &lt; 22 runin Concomitant use Phosphodiesterase 5 ( PDE5 ) inhibitor , intracavernosal injection , penile implant , Selective Serotonin Reuptake Inhibitors ( SSRI 's ) SerotoninNorepinephrine Reuptake Inhibitors ( SSNRI 's ) , tricyclic antidepressant ( example ( e.g . ) clomipramine ) , monoamine oxidase inhibitor , alpha blocker , 5 alpha reductase inhibitor ( include propecia hair loss ) , topical anaesthetic , and/or tramadol History ( last 6 month ) use Botox similar product treat premature ejaculation Unwilling stop treatment premature ejaculation ( include limited pharmacological , herbal , multiple condom , psychosexual treatment , prior masturbation ) Other sexual disorder patient partner could interfere result Current active sexually transmit disease Major medical condition patient could interfere ability sexual activity require hospital treatment Body Mass Index ( BMI ) &gt; 40 kg/m2 Participation clinical drug trial anytime 30 day prior screen Human Immunodeficiency Virus ( HIV ) hepatitis B History clinically significant prostate disease History myocardial infarction , coronary bypass surgery , coronary artery angioplasty , unstable angina , clinically evident congestive heart failure , cardiac pacemaker , cerebrovascular accident Cardiac arrhythmia : significant cardiac arrhythmia show Electrocardiogram ( ECG ) , know suspected history significant cardiac arrhythmia within last six month History congenital QT prolongation and/ correct QT ( QTc ) interval &gt; 450 millisecond ( msec ) use Bazett formula Mean systolic cuff blood pressure ( BP ) &gt; 140 millimeter mercury ( mmHg ) , assess three measurement take sequence within 510 minute last measure Mean diastolic cuff BP &gt; 90 mmHg , assess three measurement take sequence within 510 minute last measure Major psychiatric disease risk suicidal tendency assess clinical evaluation Patient Health Questionnaire ( PHQ ) 9 Columbia Suicide Assessment PHQ9 questionnaire total score &gt; 9 and/or score &gt; 0 question 9 PHQ9 , and/or suicidal ideation behavior assess Columbia Suicide Assessment Clinically significant abnormal laboratory function test result ( include liver enzymes &gt; 2 x Upper Limit Normal ( ULN ) bilirubin &gt; 1.5 x ULN ) Taking Cytochrome P450 3A4 ( CYP3A4 ) inducer , moderate potent CYP3A4 inhibitor</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>September 2016</verification_date>
</DOC>